Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The rationale for radical resection.

N K Altorki1

  • 1Cardiothoracic Surgery, Cornell Medical College, New York, New York, USA.

Surgical Oncology Clinics of North America
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026
Same author

Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
Same author

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.

Oncogene·2015
Same author

Surgical management of chylothorax.

The Thoracic and cardiovascular surgeon·2009
Same author

Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial.

The Journal of thoracic and cardiovascular surgery·2003
Same author

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Radical esophagectomy offers superior survival rates compared to standard methods and is on par with or better than combined modality therapy. This surgical approach improves staging, local control, and the likelihood of a complete R0 resection.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Surgery

Background:

  • Esophageal cancer treatment traditionally involves surgery, chemotherapy, and radiation.
  • Standard surgical techniques for esophageal cancer have limitations in achieving optimal outcomes.
  • Combined modality therapy is a common treatment approach, but its superiority over radical surgery is debated.

Purpose of the Study:

  • To evaluate the survival rates of radical esophagectomy compared to standard surgical techniques and combined modality therapy.
  • To assess the oncological benefits of radical esophagectomy, including surgical staging, local control, and R0 resection rates.

Main Methods:

  • This study compares outcomes of radical esophagectomy with historical data from standard surgical techniques and combined modality therapy.

Related Experiment Videos

  • Data analysis focused on survival rates, local recurrence, and the achievement of margin-negative (R0) resections.

    • Main Results:

    • Radical esophagectomy demonstrated survival rates exceeding those of standard surgical techniques.
    • Survival rates following radical esophagectomy were comparable to, or potentially better than, those achieved with combined modality therapy.
    • Radical resection was associated with improved surgical staging, superior local control, and a higher probability of R0 resection.

    Conclusions:

    • Radical esophagectomy is an effective treatment for esophageal cancer, offering improved survival outcomes.
    • The procedure provides significant oncological advantages, including better staging and local control.
    • Radical esophagectomy represents a viable and potentially superior alternative to standard techniques and combined modality therapy for select patients.